Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Head-to-Head Comparison of Intralesional Furosemide-Digoxin Versus Polidocanol for the Treatment of Cutaneous Warts With 6-Month Follow-up

NCT07307131 is registered in ClinicalTrials.gov with Benha University as lead sponsor.

NCT NCT07307131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07307131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Head-to-Head Comparison of Intralesional Furosemide-Digoxin Versus Polidocanol for the Treatment of Cutaneous Warts With 6-Month Follow-up
Lead sponsor
Benha University
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2024
Completion date
September 30, 2025
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous warts, human papilloma virus (hpv)